This is a study to evaluate the safety and effectiveness of a combination of a new med (ABT-335) and Crestor to each med alone in patients with dyslipidemia. The study will look at the meds' effects on patients' levels of good cholesterol, bad cholesterol, and triglycerides. This national study is currently recruiting patients.
Read moreThe JUPITER study has been the subject of countless headlines reporting the unprecedented reduction in heart attacks with the cholesterol... Read more »
A recent study has shown that a combination of Crestor and Zetia (ezetimibe) helps high-risk patients lower their cholesterol levels better than... Read more »
According to a new study, the cholesterol-lowering drug Crestor cuts the risk of stroke nearly in half in seemingly healthy people. In a trial that... Read more »
The U.S. Food and Drug Administration has approved AstraZeneca's cholesterol-lowering drug Crestor (rosuvastatin) for older adults who have healthy... Read more »
The U.S. Food and Drug Administration (FDA) has approved the cholesterol-lowering drug Crestor for kids with a genetic condition that causes high... Read more »
A panel that advises the U.S. Food and Drug Administration (FDA) has recommended that the cholesterol-lowering drug Crestor be prescribed to patients... Read more »